These trials are being conducted to test the safety and effectiveness of investigational drugs for type 2 diabetes.

What are the eligibility requirements?

Men and women between 18 and 79 years of age, who have type 2 diabetes that is not well-managed with:

• Diet and exercise only (and are not on, or have had only limited exposure to, any oral antidiabetic medications)

     OR

• Either of the following oral thiazolidinedione (TZD) antidiabetic medications:
  
  
  • Actos^® (pioglitazone HCl)
  • Avandia^® (rosiglitazone maleate)

Study participation

If you are qualified and decide to participate in one of these clinical trials, you may receive, at no cost, study-related:

• Medical care
• Research medication
• Laboratory work and evaluations
• Glucose monitoring supplies
• Diabetic and nutritional counseling

You do not need medical insurance to participate.

Actos is a registered trademark of Takeda Pharmaceuticals North America, Inc.
Avandia is a registered trademark of GlaxoSmithKline.